| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/24/2011 | US20110045571 Proteases With Modified Pro Regions |
| 02/24/2011 | US20110045570 Novel high alkaline protease and use thereof |
| 02/24/2011 | US20110045562 Development of Strains of the Thermotolerant Yeast Hansenula Polymorpha Capable of Alcoholic Fermentation of Starch and Xylan by Expression of Starch and Xylan Degrading Enzymes |
| 02/24/2011 | US20110045557 Novel Fusion Carbonic Anhydrase/Cellulose Binding Polypeptide Encoded by a Novel Hybrid Gene, and Method of Creating and Using the Same |
| 02/24/2011 | US20110045554 Heterologous expression of extremophile heat shock proteins and chaperones in microorganisms to increase tolerance to toxic compounds |
| 02/24/2011 | US20110045552 Novel gene sms 43 |
| 02/24/2011 | US20110045549 Polynucleotides encoding a feedback resistant aspartokinase from corynebacterium |
| 02/24/2011 | US20110045548 Novel hydrogen peroxide-forming nadh oxidase and dna encoding the same |
| 02/24/2011 | US20110045541 Method of nucleic acid amplification |
| 02/24/2011 | US20110045540 Baculovirus expression vector and method therewith for generating immunogenicity in a host |
| 02/24/2011 | US20110045539 Methods and Materials for the Production of Shikimic Acid |
| 02/24/2011 | US20110045538 Peptide, Use Of The Peptide, Method For The Production Of The Peptide, Solid Support Having The Peptide Immobilized Thereon, And Method For Production Of The Solid Support |
| 02/24/2011 | US20110045536 Mammalian expression vector |
| 02/24/2011 | US20110045534 Nucleic Acid Cassette For Producing Recombinant Antibodies |
| 02/24/2011 | US20110045532 Protein production method |
| 02/24/2011 | US20110045529 Method and gene for providing or enhancing nonspecific adhesive property and/or autoagglutinating property for microorganisms |
| 02/24/2011 | US20110045524 Transfection ready eukaryotic cells |
| 02/24/2011 | US20110045513 Protein electron mediator |
| 02/24/2011 | US20110045488 Methods of diagnosing myelodysplastic syndrome (mds) or leukemia using nucleic acids or fragments encoding flt3 kinase |
| 02/24/2011 | US20110045487 Methods of diagnosing myelodysplastic syndrome (mds) or leukemia using nucleic acids or fragments encoding flt3 kinase |
| 02/24/2011 | US20110045136 Polypeptides having isoamylase activity and polynucleotides encoding same |
| 02/24/2011 | US20110045098 Excitatory glycine receptors and methods |
| 02/24/2011 | US20110045023 Recombinant RSV Virus Expression Systems And Vaccines |
| 02/24/2011 | US20110045020 Nucleic acid comprising chimeric gene derived from hepatitis c virus |
| 02/24/2011 | US20110045019 Porcine torque teno virus vaccines and diagnosis |
| 02/24/2011 | US20110045018 Astrovirus species |
| 02/24/2011 | US20110045016 Utilization of recombinant influenza viruses and modified vaccinia ankara virus (mva) with genes that encode for the toxoplasma gondii sag1 and sag2 surface proteins, as vaccines against toxoplasmosis |
| 02/24/2011 | US20110045012 Anti-atheroma vaccine |
| 02/24/2011 | US20110045011 TRUNCATED RECOMBINANT MAJOR OUTER MEMBRANE PROTEIN ANTIGEN (R56) OF ORIENTIA TSUTSUGAMUSHI STRAINS KARP, KATO and GILLIAM AND ITS USE IN ANTIBODY BASED DETECTION ASSAYS AND VACCINES |
| 02/24/2011 | US20110045010 Anti-lps factor from parietaria judaica and methods of use thereof |
| 02/24/2011 | US20110045007 Fusion or linked proteins with extended half life |
| 02/24/2011 | US20110045002 Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function |
| 02/24/2011 | US20110045001 Transfection results of non-viral gene delivery systems by influencing of the innate immune system |
| 02/24/2011 | US20110045000 for inflammatory diseases such as rheumatoid arthritis; GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor); |
| 02/24/2011 | US20110044994 Human immunodeficiency virus (hiv)-neutralizing antibodies |
| 02/24/2011 | US20110044989 Zona Pellucida Binding Peptides, Expression Vectors, Compositions, and Methods for Species Specific Immunocontraception of Animals |
| 02/24/2011 | US20110044986 Anti-amyloid antibodies and uses thereof |
| 02/24/2011 | US20110044980 Dual Variable Domain Immunoglobulins and Uses Thereof |
| 02/24/2011 | US20110044976 Humanized antibodies |
| 02/24/2011 | US20110044953 Methods and Compositions for Localized Secretion of Anti-CTLA-4 Antibodies |
| 02/24/2011 | US20110044949 Oncolytic virus replicating selectively in tumor cells |
| 02/24/2011 | US20110044947 Methods of treating cardiac disorders |
| 02/24/2011 | US20110044912 Diagnostic And Therapeutic Epitope, And Transgenic Plant |
| 02/24/2011 | DE112008003232T5 Antigen-Bindungskonstrukte Antigen-binding constructs |
| 02/24/2011 | CA2772081A1 Production of propanols, alcohols, and polyols in consolidated bioprocessing organisms |
| 02/24/2011 | CA2771702A1 Catalytic domains from lysyl oxidase and loxl2 |
| 02/24/2011 | CA2771646A1 Dna ligands for aflatoxin and zearalenone |
| 02/24/2011 | CA2771597A1 Recombinant dna molecule encoding 5'utr capable of preventing inhibition of translation under environmental stresses |
| 02/24/2011 | CA2771581A1 Detection of aad-1 event das-40278-9 |
| 02/24/2011 | CA2771543A1 Control of aad-1 monocot volunteers in fields of dicot crops |
| 02/24/2011 | CA2771540A1 Recombinant avian paramyxovirus vaccine and method for making and using thereof |
| 02/24/2011 | CA2771538A1 Aad-1 event das-40278-9, related transgenic corn lines, and event-specific identification thereof |
| 02/24/2011 | CA2771528A1 Heavy metal remediation system |
| 02/24/2011 | CA2771464A1 Screening of protein candidates |
| 02/24/2011 | CA2771441A1 Antibodies for the detection of integrin complexes in ffpe material |
| 02/24/2011 | CA2771277A1 Cloning and expression of arnox protein transmembrane 9 superfamily (tm9sf), methods and utility |
| 02/24/2011 | CA2771250A1 Baculovirus-based production of biopharmaceuticals free of contaminating baculoviral virions |
| 02/24/2011 | CA2771228A1 Treatment of 'c terminus of hsp70-interacting protein' (chip) related diseases by inhibition of natural antisense transcript to chip |
| 02/24/2011 | CA2770872A1 Functional expression of yeast nitrate transporter (ynt1) in maize to improve nitrate uptake |
| 02/24/2011 | CA2770854A1 Functional expression of shuffled yeast nitrate transporter (ynt1) in maize to improve nitrate uptake under low nitrate environment |
| 02/24/2011 | CA2770762A1 Aptamers to tissue factor pathway inhibitor and their use as bleeding disorder therapeutics |
| 02/24/2011 | CA2770609A1 Albumin fused coagulation factors for non-intravenous administration in the therapy and prophylactic treatment of bleeding disorders |
| 02/24/2011 | CA2770438A1 Plants having enhanced yield-related traits and a method for making the same |
| 02/24/2011 | CA2770185A1 Fast acting snare-cleaving enzymes |
| 02/24/2011 | CA2769619A1 Targeted immunoconjugates |
| 02/24/2011 | CA2769493A1 Disease resistant tomato plants |
| 02/24/2011 | CA2769415A1 Modification of recombinant adenovirus with immunogenic plasmodium circumsporozoite protein epitopes |
| 02/24/2011 | CA2769407A1 Mimotopes of hiv and uses thereof |
| 02/24/2011 | CA2768640A1 Apolipoprotein l-i variants and their use |
| 02/23/2011 | EP2287623A1 Microanalysis chip adhesive sheet, microanalysis chip, and manufacturing method thereof |
| 02/23/2011 | EP2287619A1 Detection of foetal cells from maternal blood |
| 02/23/2011 | EP2287613A2 Detection, monitoring and treatment of cancer |
| 02/23/2011 | EP2287341A1 Nucleic acid molecules containing recombination sites and methods of using the same |
| 02/23/2011 | EP2287338A1 Process for synthesizing nucleic acid |
| 02/23/2011 | EP2287337A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours |
| 02/23/2011 | EP2287326A1 Methods of protein production in yeast |
| 02/23/2011 | EP2287323A1 Widespread gene delivery to the retina using systemic administration of AAV vectors |
| 02/23/2011 | EP2287322A1 A method of selectively producing male or female sterile plants |
| 02/23/2011 | EP2287321A1 Multiply-substituted protease variants |
| 02/23/2011 | EP2287320A1 Multiply-substituted protease variants |
| 02/23/2011 | EP2287319A1 Medical preparations for the treatment of alpha-galactosidase a deficiency |
| 02/23/2011 | EP2287318A1 Mannanases |
| 02/23/2011 | EP2287317A2 Method of producing a protein ester or a protein subunit ester |
| 02/23/2011 | EP2287316A1 Antigenic polypeptides |
| 02/23/2011 | EP2287315A1 Streptococcus pyogenes antigens |
| 02/23/2011 | EP2287314A1 Streptococcus pyogenes antigens |
| 02/23/2011 | EP2287313A1 Streptococcus pyogenes antigens |
| 02/23/2011 | EP2287312A1 Streptococcus pyogenes antigens |
| 02/23/2011 | EP2287311A1 Streptococcus pyogenes antigens |
| 02/23/2011 | EP2287310A1 Compositions and methods of use for mgd-csf in disease treatment |
| 02/23/2011 | EP2287309A1 Novel expression vectors containing accessory molecule ligand genes and their use for immunomodulation and treatment of malignancies and autoimmune disease |
| 02/23/2011 | EP2287308A2 Materials and methods for identifying and analyzing intermediate tandem repeat DNA markers |
| 02/23/2011 | EP2287307A2 Materials and methods for identifying and analyzing intermediate tandem repeat DNA markers |
| 02/23/2011 | EP2287306A1 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA) |
| 02/23/2011 | EP2287305A1 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA) |
| 02/23/2011 | EP2287304A1 Novel treatment of patients after stent implantation or balloon dilatation and novel drug eluting stents |
| 02/23/2011 | EP2287303A1 Methods and compositions involving miRNA and miRNA inhibitor molecules |
| 02/23/2011 | EP2287302A1 High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of matrix attachment region sequences |
| 02/23/2011 | EP2287301A2 Methods and compositions to inhibit P2X7 receptor expression |
| 02/23/2011 | EP2287300A1 Bacterial toxin vaccine |